Emergent BioSolutions, Inc. (EBS)
11.87
-0.03
(-0.25%)
USD |
NYSE |
Dec 08, 16:00
11.91
+0.04
(+0.34%)
Pre-Market: 20:00
Emergent BioSolutions Market Cap: 623.41M for Dec. 8, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 212.30B |
| SIGA Technologies, Inc. | 440.41M |
| Tonix Pharmaceuticals Holding Corp. | 146.33M |
| GeoVax Labs, Inc. | 12.25M |
| Black Diamond Therapeutics, Inc. | 156.68M |
Market Cap Related Metrics
| PE Ratio | 9.173 |
| PS Ratio | 0.8358 |
| Price to Book Value | 1.070 |
| Price to Free Cash Flow | 470.98 |
| Price | 11.87 |
| Earnings Yield | 10.90% |
| Operating PE Ratio | 5.684 |
| Normalized PE Ratio | 9.402 |